Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Catamenial Insulin Reactions Treated With a Long-Acting Gonadotropin Releasing Hormone Agonist

Catamenial Insulin Reactions Treated With a Long-Acting Gonadotropin Releasing Hormone Agonist Abstract Exacerbation of a variety of symptoms during the menstrual cycle is a well-described phenomenon. The exact causes of these changes are poorly understood, and no specific and efficacious therapy has been described. We successfully treated a patient with severe catamenial insulin reactions with a long-acting gonadotropin releasing hormone agonist to suppress menstrual function and added a combination of estrogen and progestin to offset any adverse effect of the resultant hypoestrogenemia for 1 year. (Arch Intern Med. 1994;154:1868-1870) References 1. Ostfeld AM. Studies in headache: migraine and the menstrual cycle . In: Kroger WS, ed. Psychosomatic Obstetrics, Gynecology, and Endocrinology . Springfield, III: Charles C Thomas Publisher; 1962:327-333. 2. Muse KN, Cetal NS, Futterman LA, Yen SSC. The premenstrual syndrome: effects of 'medical ovariectomy .' N Engl J Med. 1984;311:1345-1349.Crossref 3. Anderson KE, Spitz IM, Sassa S, Bardin W, Kappas A. Prevention of cyclic attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone . N Engl J Med. 1984;311:643-645.Crossref 4. Lenzen S, Bailey CJ. Thyroid hormone, gonadal and adrenocortical steroids and the function of the islets of Langerhans . Endocrinol Rev. 1984;5:411-434.Crossref 5. Slater JE, Raphael G, Cutler GB, Loriaux DL, Meggs WJ, Kaliner M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist: a preliminary report . Obstet Gynecol. 1987;70:542-546. 6. Espaulella J, Armengol J, Bella F, Lain JM, Calaf J. Pulmonary endometriosis: conservative treatment with GnRH agonist . Obstet Gynecol. 1991;78:535-537. 7. Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRH analogues with 'add-back' estrogen therapy . Obstet Gynecol. 1993;81:104-107. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Catamenial Insulin Reactions Treated With a Long-Acting Gonadotropin Releasing Hormone Agonist

Loading next page...
 
/lp/american-medical-association/catamenial-insulin-reactions-treated-with-a-long-acting-gonadotropin-oVK3k1LYHl
Publisher
American Medical Association
Copyright
Copyright © 1994 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1994.00420160108015
Publisher site
See Article on Publisher Site

Abstract

Abstract Exacerbation of a variety of symptoms during the menstrual cycle is a well-described phenomenon. The exact causes of these changes are poorly understood, and no specific and efficacious therapy has been described. We successfully treated a patient with severe catamenial insulin reactions with a long-acting gonadotropin releasing hormone agonist to suppress menstrual function and added a combination of estrogen and progestin to offset any adverse effect of the resultant hypoestrogenemia for 1 year. (Arch Intern Med. 1994;154:1868-1870) References 1. Ostfeld AM. Studies in headache: migraine and the menstrual cycle . In: Kroger WS, ed. Psychosomatic Obstetrics, Gynecology, and Endocrinology . Springfield, III: Charles C Thomas Publisher; 1962:327-333. 2. Muse KN, Cetal NS, Futterman LA, Yen SSC. The premenstrual syndrome: effects of 'medical ovariectomy .' N Engl J Med. 1984;311:1345-1349.Crossref 3. Anderson KE, Spitz IM, Sassa S, Bardin W, Kappas A. Prevention of cyclic attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone . N Engl J Med. 1984;311:643-645.Crossref 4. Lenzen S, Bailey CJ. Thyroid hormone, gonadal and adrenocortical steroids and the function of the islets of Langerhans . Endocrinol Rev. 1984;5:411-434.Crossref 5. Slater JE, Raphael G, Cutler GB, Loriaux DL, Meggs WJ, Kaliner M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist: a preliminary report . Obstet Gynecol. 1987;70:542-546. 6. Espaulella J, Armengol J, Bella F, Lain JM, Calaf J. Pulmonary endometriosis: conservative treatment with GnRH agonist . Obstet Gynecol. 1991;78:535-537. 7. Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRH analogues with 'add-back' estrogen therapy . Obstet Gynecol. 1993;81:104-107.

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Aug 22, 1994

References